BCL2 and Miyoshi myopathy: It has recently been reported that depletion of FAM46C in the XG1 MM cell line results in increased expression of IRF4, Bcl2 and ERK signalling activation.16 The authors proposed that these changes might explain the increased survival to dexamethasone and lenalidomide observed in this cell line.